BCL2 Protein Progressively Declines during Robust CLL Clonal Expansion: Potential Impact on Venetoclax Clinical Efficacy and Insights on Mechanism
BCL2 蛋白在慢性淋巴细胞白血病 (CLL) 克隆扩增过程中逐渐下降:对 Venetoclax 临床疗效的潜在影响及机制见解
期刊:Lymphatics
影响因子:
doi:10.3390/lymphatics2020005
Hyunjoo Lee, Shabirul Haque, Rashmi Gupta, Jonathan E Kolitz, Steven L Allen, Kanti Rai, Nicholas Chiorazzi, Patricia K A Mongini
免疫
细胞生物学
白血病
肿瘤细胞
FlowCytometry
Survivin